Rubedo Life Sciences
Latest round
- Series A
Last raised
- Apr 2024
Total raised
- $52M
Investors
- 11
About Rubedo Life Sciences
Founded in 2018 and based in California, US, Rubedo Life Sciences, Inc. operates as a biopharmaceutical company. The company was founded by its CEO, Marco Quarta, Mark Gallop, and Julian Klein. In April 2024, Rubedo Life Sciences, Inc.71 million post-money. Rubedo Life Sciences develops drugs, mainly small molecules, to target and eliminate senescent cells. The firm's lead drug candidate, RLS-1496, is a topical medication designed to remove senescent cells from skin lesions and used for the treatment of dermatological conditions.
Who invested in Rubedo Life Sciences
11 investors across 2 rounds
See all investors in Rubedo Life Sciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rubedo Life Sciences
Who invested in Rubedo Life Sciences?
Rubedo Life Sciences has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rubedo Life Sciences raised?
Rubedo Life Sciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Rubedo Life Sciences last raise money?
Rubedo Life Sciences's most recent round on record is a Series A, in Apr 2024.
What does Rubedo Life Sciences do?
Founded in 2018 and based in California, US, Rubedo Life Sciences, Inc.
Where is Rubedo Life Sciences headquartered?
Rubedo Life Sciences is headquartered in Sunnyvale, US.
Which VCs invest in companies like Rubedo Life Sciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Rubedo Life Sciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Rubedo Life Sciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.